Equity

PHSTX Putnam Global Health Care Fund

  • Research-intensive process. Combines deep fundamental research with technical expertise and actively monitors scientific innovation and regulatory changes to identify opportunities.
  • Innovation-driven growth. Seeks to harness the steady, global demand for innovative health care solutions to pursue attractive returns regardless of economic conditions.
  • Concentrated, best-ideas approach. Pursues alpha over a full market cycle by combining a bottom-up approach and disciplined risk management to build a focused portfolio of 30–50 high-conviction names.
NAV 1 $0.01(0.02%)
$63.18
As of 11/13/2025
YTD Total Returns At NAV 2
13.33%
As of 11/13/2025
Total Net Assets
$1.49B
As of 10/31/2025 (Updated Monthly)
Morningstar Overall Rating™ 3
As of 10/31/2025

Sign in to view documents

This feature is not available at your firm

Skipped to Overview Section Content

Overview

Fund Facts

Fund description

The fund seeks capital appreciation. Combines deep fundamental research with technical expertise and actively monitors scientific innovation and regulatory changes to identify opportunities.

Benchmark
MSCI World Health Care Index-NR
Fund Inception Date
05/28/1982
Dividend Frequency, if any
Annually
Portfolio Turnover
67%

Sales Charges, Expenses & Fees

As of 12/30/2024
Gross Expense Ratio4
1.05%
Net Expense Ratio4,5
1.05%
Maximum Initial Charge
5.75%
CDSC
1.00%
12b-1 Fee
0.25%

Identifiers

Ticker
PHSTX
Fund Number
013
CUSIP Code
746778109

Average Annual Total Returns

View performance section for additional info As of 10/31/2025

Class A

  • -6.99%1 Year
  • 4.90%3 Years
  • 7.46%5 Years
  • 6.99%10 Years
  • 11.13%Since Inception
    05/28/1982

Performance data quoted represents past performance, which does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the figures shown.

Top Sectors

View portfolio section for additional info

As of 10/31/2025 % of Total (Updated Monthly)

Pharmaceuticals39.40%
Biotechnology21.06%
Health Care Equipment14.52%
Managed Health Care6.49%
Life Sciences Tools & Services5.25%

Additional Fund Info

Share Class Inception Date
05/28/1982
Investment Style
Sector
Lipper Classification
Global Health/Biotechnology Funds
Morningstar Category
Health

Sign in to view documents

Manager and Commentary

About the Team

Putnam Investments

Putnam Investments has been serving clients and shareholders for over 85 years. We manage a range of equity portfolios with a focus on stock-specific opportunities. Our approach — stock-driven rather than style-driven — is designed to offer consistent outperformance, regardless of the market environment. Our portfolios are fueled by a variety of independent views and perspectives, enhanced by fundamental research and ongoing dialogue and debate. We combine this with portfolio construction that aims to reduce broader macro exposures and manage downside risk.

Putnam Investments
[Mike Maguires avatar]

Managed Fund Since 2016

Portfolio Manager Profile
Years of Experience
Manager Location

Sign in to view documents

Sign in to view documents

Skipped to Performance Section Content

Performance

Calendar Year Returns

As of 10/31/2025

Chart

Bar chart with 2 data series.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from -11.68 to 30.23.
End of interactive chart.
Class A - Without Sales Charge (NAV) (%)
MSCI World Health Care Index-NR (%)

Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment returns will fluctuate, and investors' shares, when redeemed, may be worth more or less than the original cost. Performance would have been lower if fees had not been waived in various periods. Total returns assume the reinvestment of all distributions and the deduction of all Fund expenses. Returns with sales charge reflect a deduction of the stated maximum sales charge. Returns without sales charge would have been lower had sales charges been reflected. An investor cannot invest directly in an index, and unmanaged index returns do not reflect any fees, expenses or sales charges. Returns for periods of less than one year are not annualized. 

See the risks and other important information.

Ratings 3

Morningstar logo
Overall Morningstar Rating
Overall Morningstar Rating: 4 out of 5 stars  
As of 10/31/2025
3 Years
3 Years: 4 out of 5 stars  
165 Funds in category
5 Years
5 Years: 5 out of 5 stars  
152 Funds in category
10 Years
10 Years: 4 out of 5 stars  
118 Funds in category
Rating Category
Health

The fund's overall Morningstar Rating measures risk-adjusted returns and is derived from a weighted average of the performance figures associated with its 3-, 5- and 10-year (if applicable) rating metrics. 

Morningstar Style Box
As of 10/31/2025
Current Historical
Large
Medium
Small
Value Blend Growth
Style
Size

Source: Morningstar®. The style box reveals a fund's investment style. For equity funds, the vertical axis shows the market capitalization of the long stocks owned, and the horizontal axis shows the investment style (value, blend, or growth). For fixed income funds, the vertical axis shows the credit quality based on credit ratings and the horizontal axis shows interest-rate sensitivity as measured by effective duration. Placement is determined by fund portfolio holding figures most recently entered into Morningstar's database and corresponding market conditions. Shaded areas show the past 3 years of quarterly data. Past performance does not guarantee future results.

©2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Skipped to Portfolio Section Content

Portfolio

Assets

As of10/31/2025 (Updated Monthly)

Total Net Assets
$1.49 Billion

Positions

As of 10/31/2025 (Updated Monthly)

Number of Issuers
Fund
39

Portfolio Statistics

As of 10/31/2025 (Updated Monthly)

Price to Book
Fund
5.10x
Price to Earnings (12-Month Forward)
Fund
20.02x
Weighted Average Market Capitalization (USD)
Fund
$273.04 Billion

Market Capitalization Allocation

As of 10/31/2025 % of Total (Updated Monthly)

Market Capitalization Fund
Less than $1.4B 3.18%
$1.4B - $5.2B 1.03%
$5.2B - $30.6B 4.46%
$30.6B - $130.7B 22.43%
Over $130.7B 66.73%
Cash and other assets 2.15%

Chart

Bar chart with 6 bars.
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying values. Data ranges from 1.03247 to 66.73218.
End of interactive chart.

Holdings

As of 09/30/2025 (Updated Monthly)

ELI LILLY & CO SEDOL 2516152
ABBVIE INC SEDOL B92SR70
UNITEDHEALTH GROUP INC SEDOL 2917766
JOHNSON & JOHNSON SEDOL 2475833
ASTRAZENECA PLC SEDOL 0989529
THERMO FISHER SCIENTIFIC INC SEDOL 2886907
NOVARTIS AG-REG SEDOL 7103065
BOSTON SCIENTIFIC CORP SEDOL 2113434
ABBOTT LABORATORIES SEDOL 2002305
MCKESSON CORP SEDOL 2378534
Skipped to Distributions Section Content

Distributions & Tax

Distribution Frequency
AnnuallyThis fund is an ex-Dividend fund
Capital Gain Distributions
December

Final composition of the current year’s distribution—income, capital gains and/or return of capital—are based on US tax rules and will be determined by February of the following year. For tax characterization of a distribution, such as return of capital and tax-exempt income, click on the “Tax Information” tab above.

Distributions Per Share
Distribution amounts may be estimates

12/22/2025
Skipped to Pricing Section Content

Pricing

Pricing History

As of 11/13/2025 (Updated Daily)

Chart

Line chart with 10584 data points.
The chart has 1 X axis displaying Time. Data ranges from 1982-05-28 00:00:00 to 2025-11-13 00:00:00.
The chart has 1 Y axis displaying [products.performance-value]. Data ranges from 13.52 to 86.95.
End of interactive chart.

Daily Fund Prices

As of 11/13/2025

Share Prices

As of 11/13/2025

NAV  1(Net Asset Value)
$63.18
NAV Change  1
$0.01
NAV Change (%)  1
0.02%
POP  6(Public Offering Price)
$67.03

52-Week Range

Highest NAV As of 11/13/2025
$63.18
Lowest NAV As of 05/14/2025
$52.11

Sign in to view documents

Skipped to Documents Section Content

Documents

Fund Literature
Name Download Add to Cart
Factsheet - Putnam Global Health Care FundDownload Document
Regulatory Documents
Name Download Add to Cart
Annual Report - Putnam Global Health Care Fund - Class ADownload Document
Annual Financial Statements and Other Information - Putnam Global Health Care FundDownload Document
Semi-Annual Report - Putnam Global Health Care Fund - Class ADownload Document
Semi-Annual Financial Statements and Other Information - Putnam Global Health Care FundDownload Document
Prospectus - Putnam Global Health Care FundDownload Document
Summary Prospectus - Putnam Global Health Care FundDownload Document
Statement Of Additional Information - Putnam Global Health Care FundMailed hardcopies unavailable.Download Document
Policy and Procedures - Putnam Global Health Care FundMailed hardcopies unavailable.Download Document
Fiscal Q1 Holdings - Putnam Global Health Care FundMailed hardcopies unavailable.Download Document
Fiscal Q3 Holdings - Putnam Global Health Care FundMailed hardcopies unavailable.Download Document

Sign in to view documents

Risks

All investments involve risks, including possible loss of principal. International investments are subject to special risks, including currency fluctuations and social, economic and political uncertainties, which could increase volatility. These risks are magnified in emerging markets. Small- and mid-cap stocks involve greater risks and volatility than large-cap stocks. The investment style may become out of favor, which may have a negative impact on performance. To the extent the portfolio invests in a concentration of certain securities, regions or industries, it is subject to increased volatility. The portfolio is non-diversified and may invest in a relatively small number of issuers, which may negatively impact the performance and result in greater fluctuation in value. Derivative instruments can be illiquid, may disproportionately increase losses, and have a potentially large impact on performance. Active management does not ensure gains or protect against market declines. The manager may consider environmental, social and governance (ESG) criteria in the research or investment process; however, ESG considerations may not be a determinative factor in security selection. In addition, the manager may not assess every investment for ESG criteria, and not every ESG factor may be identified or evaluated. These and other risks are discussed in the fund's prospectus.

Sign in to view documents

Most funds offer multiple share classes. Share classes are subject to different fees and expenses, which will affect their performance. 

Certain share classes are only offered to eligible investors as stated in the prospectus. Different minimums may apply to clients of certain service agents. All classes of shares are not available through all distribution channels. See the Fund's prospectus for additional information.

You need Adobe Acrobat Reader to view and print PDF documents. Download a free version from Adobe's website.

Important data provider notices and terms available at www.franklintempletondatasources.com.

Performance data quoted represents past performance, which does not guarantee future results. 

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.

Indexes are unmanaged and one cannot invest directly in an index. They do not reflect any fees, expenses or sales charges. 

The MSCI World Health Care Index is a free float-adjusted market capitalization-weighted index that is designed to measure the equity market performance of developed markets in the health care sector. Source: MSCI makes no warranties and shall have no liability with respect to any MSCI data reproduced herein. No further redistribution or use is permitted. This report is not prepared or endorsed by MSCI.
Net Returns (NR) include income net of tax withholding when dividends are paid.

Investors should carefully consider a fund's investment goals, risks, sales charges and expenses before investing. The prospectus contains this and other information. Please read the prospectus carefully before investing or sending money.

Putnam funds are not exchangeable for other funds distributed by Franklin Distributors, LLC. 

Franklin Distributors, LLC. Member FINRA/SIPC. Putnam Investment is a Franklin Templeton company. Investment Products: NOT FDIC INSURED | NO BANK GUARANTEE | MAY LOSE VALUE.

Reports and other information about the funds are available on the EDGAR Database on the SEC's Internet site at www.sec.gov

Footnotes

  1. Net Asset Value - the amount per share you would receive if you sold shares that day. NAV Change indicates a change in the Net Asset Value from the previous business day.

  2. Figures are aggregate total return figures, have not been annualized and represent the change in value of an investment over the period indicated.

  3. The Morningstar Rating™ for funds, or “star rating”, is calculated for managed products with at least a three-year history, and subject to change monthly. Exchange-traded funds and open-ended mutual funds are considered a single population for comparative purposes. It is calculated based on a Morningstar Risk Adjusted Return measure that accounts for variation in a managed product’s monthly excess performance, placing more emphasis on downward variations and rewarding consistent performance. The top 10% of products in each product category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars, and the bottom 10% receive 1 star. The Overall Morningstar Rating is derived from a weighted average of the performance figures associated with its three-, five-, and 10-year (if applicable) Morningstar Rating metrics. The weights are: 100% three-year rating for 36-59 months of total return, 60% five-year rating/40% three-year rating for 60-119 months of total returns, and 50% 10-year rating/30% five-year rating/20% three-year rating for 120 or more months of total return. While the 10-year overall star rating formula seems to give the most weight to the 10-year period, the most recent three-year period actually has the greatest impact because it is included in all three rating periods. Ratings do not take into account the effects of sales charges and loads. Morningstar Rating is for the specified share class(es) only; other classes may have different performance characteristics. 
    ©2025 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

  4. Gross Expense Ratio reflects the total annual operating expenses for the share class shown, prior to the deduction of any waiver or reimbursement. Actual expenses may be higher and may impact portfolio returns. Net Expense Ratio reflects total expenses after any fee waivers, implemented expense caps or reimbursements. If a fund has contractual fee waivers, expense caps and/or reimbursements, the expiration date can be found by clicking on the information button next to the net expense ratio. Additional amounts may be voluntarily waived and/or reimbursed and may be modified or discontinued at any time without notice. Expense ratios are as of the most recent prospectus or annual report.

  5. Net Expense Ratio represents the expense ratio applicable to investors. 

  6. Public Offering Price – the purchase price for each share of the fund on a given day.  It includes the maximum initial sales charge, if any.